Expanded Access Program of Neladalkib (NVL-655) for Patients With Advanced ALK+ NSCLC or Other ALK+ Solid Tumors
Clinical trial NCT06834074 · AVAILABLE
Trial details
- NCT number
- NCT06834074
- Sponsor
- Nuvalent Inc.
- Status
- AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.